IPSC — CENTURY THERAPEUTICS

Ownership history in Syncona Portfolio Ltd  ·  7 quarters on record

This page tracks every 13F SEC filing in which Syncona Portfolio Ltd reported a position in CENTURY THERAPEUTICS (IPSC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
3.52% (2025 Q4)
Avg. % of fund
2.5%
First filed
2024 Q2
Last filed
2025 Q4
Quarters held
7
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 1,213,056 — 0% 3.52% $1.21B $1.00
2025 Q3 UNCHANGED 1,213,056 — 0% 2.18% $604.1M $0.50
2025 Q2 UNCHANGED 1,213,056 — 0% 1.76% $678.1M $0.56
2025 Q1 UNCHANGED 1,213,056 — 0% 2.19% $577.4M $0.48
2024 Q4 UNCHANGED 1,213,056 — 0% 2.31% $1.23B $1.01
2024 Q3 ADDED 1,213,056 +212,285 +21.2% 2.57% $2.07B $1.71
2024 Q2 INITIATED 1,000,771 — — 2.97% $2.55B —
% of Fund (quarterly)    IPSC price (monthly, adj. close)

Other funds also holding IPSC

As of 2025 Q4 — sorted by position size

DAFNA Capital Management LLC 3Y 7Y 0.65% SUPERSTRING CAPITAL MANAGEMENT LP 0.25% Casdin Capital, LLC 3Y 7Y 0.08% Parametrica Management Ltd 3Y 7Y 0.04% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.03% HARBOURVEST PARTNERS LLC 3Y 7Y 0.02% Scientech Research LLC 0.01% Point72 Asset Management, L.P. 3Y 7Y 0.01% ADAGE CAPITAL PARTNERS GP, L.L.C. 3Y 7Y 0.0% Quadrant Private Wealth Management, LLC 3Y 7Y 0.0%
← Back to Syncona Portfolio Ltd Holdings